Innovation in Clinical Trial Methodologies: Lessons Learned during the Corona Pandemic presents a selection of updated chapters from Re-Engineering Clinical Tri

On March 3-4, 2016, the National Academies of Sciences, Engineering, and Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop in Washin

The pharmaceutical industry is currently operating under a business model that is not sustainable for the future. Given the high costs associated with drug deve

Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge an

Recent scientific and technological advances have accelerated our understanding of the causes of disease development and progression, and resulted in innovative